Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-30
1996-02-06
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540492, 544316, C07D23922, A61K 31305
Patent
active
054895944
ABSTRACT:
This invention relates to compounds having the following formula ##STR1## or a pharmaceutically acceptable salt thereof which are useful in the inhibition of platelet aggregation, to pharmaceutical compositions of such phenylamidines derivatives, and to a method of inhibiting platelet aggregation in mammals by administering such compounds and compositions.
REFERENCES:
patent: 5272162 (1993-12-01), Tjoeng et al.
patent: 5314902 (1994-05-01), Tjoeng et al.
patent: 5344837 (1994-09-01), Tjoeng et al.
U.S. patent applicatiion Ser. No. 07/847,260, filed Mar. 6, 1992, Bovy, et al.
U.S. patent application Ser. No. 08/019,923, filed Feb. 19, 1993, Tjoeng, et al.
Bovy Philippe R.
Rico Joseph G.
Rogers Thomas E.
G. D. Searle & Co.
Gerstl Robert
Kovacevic Cynthia S.
Williams Roger A.
LandOfFree
Platelet aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet aggregation inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175304